글로벌 유전성 감각 운동 신경병 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 유전성 감각 운동 신경병 시장

유전성 감각 운동 신경병 시장은 2021년에서 2028년까지의 예측 기간 동안 5.70%의 시장 성장을 목격할 것으로 예상됩니다. 유전성 감각 운동 신경병 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 동안 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 퇴행성 신경 질환의 유병률이 증가함에 따라 유전성 감각 운동 신경병 시장 성장이 가속화되고 있습니다.

유전성 운동 감각 신경병증(HMSN)은 샤르코-마리-투스병이라고도 하며, 다리에 더 두드러지는 약함과 무감각을 동반한 신경의 유전적 진행성 질환을 말합니다. 손과 발의 근육은 더 이상 신경에서 정상적인 자극을 받지 못하기 때문에 약해지는 경향이 있습니다. 이 질환의 증상은 매우 다양하며 신경 세포의 일부가 악화됩니다.

전 세계 인구 중 유전성 운동 감각 신경병증(HMSN) 또는 샤르코-마리-투스병의 발병률이 증가하는 것은 유전성 감각 운동 신경병증 시장 성장을 견인하는 주요 요인 중 하나로 작용합니다. 유전자 돌연변이 로 인한 퇴행성 질환 사례가 증가 하고 장애를 역전시키기 위한 변형 치료법을 제공하는 새로운 기술 개발이 도입되면서 시장 성장이 가속화됩니다. 피로 , 통증, 무감각, 균형 감각 상실, 시력 및 청력 등과 같은 유전성 운동 감각 신경병증과 관련된 합병증을 치료하기 위한 약물 에 대한 높은 수요 와 연구 프로젝트를 위한 기금으로 정부가 취한 이니셔티브는 시장에 더 큰 영향을 미칩니다. 또한 투자 급증, 노인 인구 증가 및 향상된 의료 서비스는 유전성 감각 운동 신경병증 시장에 긍정적인 영향을 미칩니다. 더욱이 치료법의 발전은 2021년에서 2028년의 예측 기간 동안 시장 참여자에게 수익성 있는 기회를 확대합니다.

On the other hand, high cost associated with the treatment and diagnosis of hereditary sensory motor neuropathy is expected to obstruct the market growth. Limited treatments available are projected to challenge the hereditary sensory motor neuropathy market in the forecast period of 2021-2028.

This hereditary sensory motor neuropathy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info hereditary sensory motor neuropathy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Hereditary Sensory Motor Neuropathy Market Scope and Market Size

The hereditary sensory motor neuropathy market is segmented on the basis of diagnosis, treatment, distribution channel and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of diagnosis, the hereditary sensory motor neuropathy market is segmented into EMGs and motor nerve conduction test, specialized DNA blood tests, molecular genetic testing, and others.
• On the basis of treatment, the hereditary sensory motor neuropathy market is segmented into surgery, drugs, and others.
• On the basis of distribution channel, the hereditary sensory motor neuropathy market is segmented into hospital pharmacies, and retail and online pharmacies.
• On the basis of end user, the hereditary sensory motor neuropathy market is segmented into hospitals, homecare, specialty clinics, and others.

Global Hereditary Sensory Motor Neuropathy Market Country Level Analysis

The hereditary sensory motor neuropathy market is analyzed and market size information is provided by country, diagnosis, treatment, distribution channel and end user  as referenced above.

The countries covered in the global hereditary sensory motor neuropathy market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the hereditary sensory motor neuropathy market due to the developed healthcare infrastructure within the region. Asia-Pacific is expected to witness high growth during the forecast period of 2021 to 2028 because of the developing economy in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The hereditary sensory motor neuropathy market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Hereditary Sensory Motor Neuropathy Market Share Analysis

The hereditary sensory motor neuropathy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related hereditary sensory motor neuropathy market.

유전성 감각 운동 신경병증 시장 보고서에 포함된 주요 기업으로는 Pfizer Inc., Novartis AG, Allergan, AbbVie Inc., Bausch Health Companies Inc., Abbott., Johnson & Johnson Private Limited, Regeneron Pharmaceuticals Inc., Mallinckrodt company., Swedish Orphan Biovitrum AB 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-63606